REQUEST A DEMO
Total
USD $0.00
Search more companies

Naerusuine OU (Estonia)

Main Activities: Pharmacies and Drug Stores
Full name: Naerusuine OU Profile Updated: November 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Naerusuine OU is based in Estonia, with the head office in Tallinn. It operates in the Pharmacies and Drug Stores sector. It was established on February 21, 2020. It currently has a total number of 23 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 10.87% in 2024. Over the same period, its total assets grew by 17.03%.

Headquarters
Linnamae tee 3 Lasnamae linnaosa
Tallinn; Harju county; Postal Code: 13912

Contact Details: Purchase the Naerusuine OU report to view the information.

Basic Information
Total Employees:
Purchase the Naerusuine OU report to view the information.
Registered Capital:
Purchase the Naerusuine OU report to view the information.
Financial Auditors:
Purchase the Naerusuine OU report to view the information.
Incorporation Date:
February 21, 2020
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Naerusuine OU report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
10.87%
Total operating revenue
10.87%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
17.03%
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
14.36%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?